Press releases found on our website are intended as reference information for investors and journalists. The information contained in each press release was accurate at the time of issuance and caprotec™ bioanalytics GmbH assumes no responsibility for updating the information to reflect subsequent developments.
caprotec bioanalytics Announces Commercial Launch Of Three New caproKits™ For Applications In Proteomics And Drug Development
Berlin, Germany and Burlington, MA, January 26, 2010 - caprotec bioanalyitcs GmbH anounced today the commercial launch of three new caporKits™, enabling the discovery, identification and characterization of proteins belonging to the group of metallo-proteases, histon-eacetylases and GDP/GTP binding proteins. Download
Germany-based caprotec bioanalytics opens US Subsidiary in Burlington, Massachusetts; Appoints President
Burlington, MA, and Berlin, Germany, November 19, 2009 - caprotec bioanalytics GmbH ammounced today the opening of its US subsidiary based in Burlington, MA. caprotec Inc. will be responsible for North American sales, marketing and support of caprotec´s proprietary Capture Compound Mass Spectrometry (CCMS) technology and its related products. Download
caprotec bioanalytics announces launch of new Stauro caproKit™ for signal transduction research and drug development
Berlin, Germany, May 13, 2009 - caprotec bioanalytics GmbH announced today the commercial launch of its Stauro caproKit™, enabling the discovery, identification and characterization of proteins interacting with staurosporine. Download
caprotec bioanalytics announces the appointment of Funakoshi as distributor for its products on the Japanese market
Berlin, Germany, February 09, 2009 - caprotec bioanalytics GmbH announced today that they entered into an exclusive distributorship agreement with Funakoshi Co. Ltd. for the marketing and sales of caprotec´s research products in the country of Japan. Download
caprotec bioanalytics announces launch of new products for research and drug development
Berlin, Germany, January 19, 2009 - caprotec bioanalytics GmbH announced today that they completed the commercial launch of their first two caproKits™. Download
caprotec bioanalytics awarded 0,6 m € grant for research and development
Berlin, Germany, December 15, 2008 – caprotec bioanalytics GmbH announced today that they won a grant of up to 0,6 m € over a period of 2 years. Download
caprotec bioanalytics adds two patents to its significant patent estate
Berlin, Germany, December 2, 2008 – caprotec bioanalytics GmbH announced today that the Canadian Patent Office hase granted two Canadian patents covering the company's revolutionary Capture Compound Mass Spectrometry (CCMS) technology. Download
caprotec bioanalytics and Merck KGaA Sign Collaboration Agreement
Berlin, Germany, May 28, 2008 – caprotec bioanalytics GmbH announced today that they have signed a collaboration agreement with Merck KGaA acting for its division Merck Serono. Download
caprotec bioanalytics GmbH Appoints Dr. Mathias Grote as Chief Financial and Chief Operating Officer
Berlin, Germany, March 13, 2008 – caprotec bioanalytics GmbH announced today the appointment of Dr. Mathias Grote as Chief Financial Officer and Chief Operating Officer of the Company. Download
Life Science Startup caprotec bioanalytics Receives Additional Venture Capital Funding
Berlin, Germany, January 10, 2008 – caprotec bioanalytics GmbH receives a total of EUR 6 million ($8.8M) in two rounds of financing. Download
